Number of the records: 1  

14-3-3-protein regulates Nedd4-2 by modulating interactions between HECT and WW domains

  1. 1.
    SYSNO ASEP0544647
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    Title14-3-3-protein regulates Nedd4-2 by modulating interactions between HECT and WW domains
    Author(s) Pohl, Pavel (FGU-C) ORCID
    Joshi, Rohit (FGU-C)
    Petrvalská, Olivia (FGU-C) RID, ORCID, SAI
    Obšil, Tomáš (FGU-C) RID, ORCID
    Obšilová, Veronika (FGU-C) RID, ORCID, SAI
    Article number899
    Source TitleCommunications Biology. - : Nature Publishing Group
    Roč. 4, č. 1 (2021)
    Number of pages15 s.
    Languageeng - English
    CountryGB - United Kingdom
    Keywordsprotein structure and function ; ubiquitination ; 14-3-3 protein ; Nedd4-2 ubiquitin ligase ; phosphorylation
    Subject RIVCE - Biochemistry
    OECD categoryBiochemistry and molecular biology
    R&D ProjectsGA20-00058S GA ČR - Czech Science Foundation (CSF)
    Research InfrastructureCIISB - 90043 - Masarykova univerzita
    Method of publishingOpen access
    Institutional supportFGU-C - RVO:67985823
    UT WOS000680395000002
    EID SCOPUS85111089437
    DOI10.1038/s42003-021-02419-0
    AnnotationNeural precursor cell expressed developmentally down-regulated 4 ligase (Nedd4-2) is an E3 ubiquitin ligase that targets proteins for ubiquitination and endocytosis, thereby regulating numerous ion channels, membrane receptors and tumor suppressors. Nedd4-2 activity is regulated by autoinhibition, calcium binding, oxidative stress, substrate binding, phosphorylation and 14-3-3 protein binding. However, the structural basis of 14-3-3-mediated Nedd4-2 regulation remains poorly understood. Here, we combined several techniques of integrative structural biology to characterize Nedd4-2 and its complex with 14-3-3. We demonstrate that phosphorylated Ser342 and Ser448 are the key residues that facilitate 14-3-3 protein binding to Nedd4-2 and that 14-3-3 protein binding induces a structural rearrangement of Nedd4-2 by inhibiting interactions between its structured domains. Overall, our findings provide the structural glimpse into the 14-3-3-mediated Nedd4-2 regulation and highlight the potential of the Nedd4-2:14-3-3 complex as a pharmacological target for Nedd4-2-associated diseases such as hypertension, epilepsy, kidney disease and cancer.
    WorkplaceInstitute of Physiology
    ContactLucie Trajhanová, lucie.trajhanova@fgu.cas.cz, Tel.: 241 062 400
    Year of Publishing2022
    Electronic addresshttps://doi.org/10.1038/s42003-021-02419-0
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.